ea0038p6 | Bone | SFEBES2015
Pereira Marie
, Gohin Stephanie
, Lund Nina
, Hvid Anne
, Smitham Peter
, Oddy Michael
, Reichert Ines
, Chenu Chantal
Type 2 Diabetes Mellitus (T2DM) is associated with decreased bone quality and a higher prevalence of fractures. Sclerostin is an inhibitor of bone formation produced by osteocytes and its expression is elevated in serum of diabetic patients. We examined the effect of T2DM on bone architecture and sclerostin levels in a rat model of T2DM and the influence of hyperglycaemia on sclerostin production by bone cells in vitro. Bone architecture was measured by microCT in 14 ...